Gene · 58508
Papers4,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Intestinal-Type Adenocarcinoma in Head and Neck: Dissecting Oncogenic Gene Alterations Through Whole Transcriptome and Exome Analysis. | Mod Pathol | 2024 | 37914089 | PubTator, text mining | PubMed |
| Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection. | Int J Cancer | 2024 | 37908048 | PubTator, text mining | PubMed |
| Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study. | Thyroid | 2024 | 37842841 | PubTator, text mining | PubMed |
| Spontaneous remission and loss of monosomy 7: a window of opportunity for young children with SAMD9L syndrome. | Haematologica | 2024 | 37584291 | PubTator, text mining | PubMed |
| The Relationship Between Gene Mutations and the Clinicopathological Features and Prognosis of Gastric Cancer. | Int J Surg Pathol | 2024 | 37545327 | PubTator, text mining | PubMed |
| Circulating Tumor DNA Reflects Histologic and Clinical Characteristics of Various Lymphoma Subtypes. | Cancer Res Treat | 2024 | 37475138 | PubTator, text mining | PubMed |
| A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial. | Cancer Res Treat | 2024 | 37475136 | PubTator, text mining | PubMed |
| Characteristics and prognosis of EGFR mutations in small cell lung cancer patients in the NGS era. | Clin Transl Oncol | 2024 | 37436674 | PubTator, text mining | PubMed |
| SETD2 loss in renal epithelial cells drives epithelial-to-mesenchymal transition in a TGF-β-independent manner. | Mol Oncol | 2024 | 37418588 | PubTator, text mining | PubMed |
| Biallelic variants in RBM42 cause a multisystem disorder with neurological, facial, cardiac, and musculoskeletal involvement. | Protein Cell | 2024 | 37294900 | PubTator, text mining | PubMed |
| Epigenetic modulation of cell fate during pancreas development. | Trends Dev Biol | 2023 | 38873037 | PubTator, text mining | PubMed |
| Sexual dimorphism in bladder cancer: a review of etiology, biology, diagnosis, and outcomes. | Front Pharmacol | 2023 | 38283839 | PubTator, text mining | PubMed |
| Multiple Genomic Alterations, Including a Novel AFF4::IRF1 Fusion Gene, in a Treatment-Refractory Blastic Plasmacytoid Dendritic-Cell Neoplasm: A Case Report and Literature Review. | Int J Mol Sci | 2023 | 38203475 | PubTator, text mining | PubMed |
| Targeting Farnesoid X Receptor in Tumor and the Tumor Microenvironment: Implication for Therapy. | Int J Mol Sci | 2023 | 38203175 | PubTator, text mining | PubMed |
| Cell-Free DNA Genomic Profiling and Its Clinical Implementation in Advanced Prostate Cancer. | Cancers (Basel) | 2023 | 38201475 | PubTator, text mining | PubMed |
| A methylation-related signature for predicting prognosis and sensitivity to first-line therapies in gastric cancer. | J Gastrointest Oncol | 2023 | 38196539 | PubTator, text mining | PubMed |
| A model for predicting clinical prognosis based on brain metastasis-related genes in patients with breast cancer. | Transl Cancer Res | 2023 | 38192988 | PubTator, text mining | PubMed |
| Progress of non-small-cell lung cancer with ROS1 rearrangement. | Front Mol Biosci | 2023 | 38187090 | PubTator, text mining | PubMed |
| Identification of genes associated with gall bladder cell carcinogenesis: Implications in targeted therapy of gall bladder cancer. | World J Gastrointest Oncol | 2023 | 38173427 | PubTator, text mining | PubMed |
| Multiomics insights on the onset, progression, and metastatic evolution of breast cancer. | Front Oncol | 2023 | 38169859 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58508/papers?page=16